Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Drug Discovery Today|September 5, 2012
High-content multiplexed tissue imaging and quantification for cancer drug discoveryBeverly L Falcon, Julie Stewart, Scharri Ezell, et al.The American Journal of Medicine|March 22, 2026
Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysisLouis J Aronne, Deborah B Horn, Alexander D Kokkinos, et al.Plos One|September 12, 2014
An in vitro cord formation assay identifies unique vascular phenotypes associated with angiogenic growth factorsBeverly L Falcon, Michelle Swearingen, Wendy H Gough, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human NeuroblastomaCaitlin D Lowery, Alle B VanWye, Michele Dowless, et al.The New England Journal of Medicine|May 12, 2025
Tirzepatide as Compared with Semaglutide for the Treatment of ObesityLouis J Aronne, Deborah Bade Horn, Carel W le Roux, et al.Journal of Hematology & Oncology|April 30, 2013
Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibitionBeverly L Falcon, Belinda O'Clair, Don McClure, et al.Molecular Cancer Therapeutics|February 22, 2019
Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor InhibitionAnthony S Fischl, Xiaoen Wang, Beverly L Falcon, et al.Oncotarget|March 24, 2018
Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumorsBruce W Konicek, Andrew R Capen, Kelly M Credille, et al.Cancer Research|May 20, 2016
Stromal-Based Signatures for the Classification of Gastric CancerMark T Uhlik, Jiangang Liu, Beverly L Falcon, et al.Pageof 3